China · Delayed Price · Currency is CNY Walvax Biotechnology Statistics
Total Valuation
SHE:300142 has a market cap or net worth of CNY 20.74 billion. The enterprise value is 21.20 billion.
| Market Cap | 20.74B |
| Enterprise Value | 21.20B |
Important Dates
The last earnings date was Saturday, August 29, 2026.
| Earnings Date | Aug 29, 2026 |
| Ex-Dividend Date | Jun 24, 2026 |
Share Statistics
SHE:300142 has 1.60 billion shares outstanding. The number of shares has increased by 1.20% in one year.
| Current Share Class | 1.60B |
| Shares Outstanding | 1.60B |
| Shares Change (YoY) | +1.20% |
| Shares Change (QoQ) | -0.10% |
| Owned by Insiders (%) | 6.38% |
| Owned by Institutions (%) | 14.67% |
| Float | 1.47B |
Valuation Ratios
The trailing PE ratio is 110.53.
| PE Ratio | 110.53 |
| Forward PE | n/a |
| PS Ratio | 9.89 |
| PB Ratio | 2.83 |
| P/TBV Ratio | 3.39 |
| P/FCF Ratio | 1,125.60 |
| P/OCF Ratio | 37.84 |
| PEG Ratio | n/a |
Enterprise Valuation
The stock's EV/EBITDA ratio is 38.42, with an EV/FCF ratio of 1,150.54.
| EV / Earnings | 112.32 |
| EV / Sales | 10.11 |
| EV / EBITDA | 38.42 |
| EV / EBIT | 112.29 |
| EV / FCF | 1,150.54 |
Financial Position
The company has a current ratio of 2.07, with a Debt / Equity ratio of 0.18.
| Current Ratio | 2.07 |
| Quick Ratio | 1.70 |
| Debt / Equity | 0.18 |
| Debt / EBITDA | 2.35 |
| Debt / FCF | 70.47 |
| Interest Coverage | 11.02 |
Financial Efficiency
Return on equity (ROE) is 1.97% and return on invested capital (ROIC) is 1.93%.
| Return on Equity (ROE) | 1.97% |
| Return on Assets (ROA) | 0.96% |
| Return on Invested Capital (ROIC) | 1.93% |
| Return on Capital Employed (ROCE) | 2.21% |
| Weighted Average Cost of Capital (WACC) | 7.25% |
| Revenue Per Employee | 1.06M |
| Profits Per Employee | 95,292 |
| Employee Count | 1,981 |
| Asset Turnover | 0.17 |
| Inventory Turnover | 0.83 |
Taxes
In the past 12 months, SHE:300142 has paid 45.09 million in taxes.
| Income Tax | 45.09M |
| Effective Tax Rate | 20.19% |
Stock Price Statistics
The stock price has increased by +5.28% in the last 52 weeks. The beta is 0.62, so SHE:300142's price volatility has been lower than the market average.
| Beta (5Y) | 0.62 |
| 52-Week Price Change | +5.28% |
| 50-Day Moving Average | 13.30 |
| 200-Day Moving Average | 12.59 |
| Relative Strength Index (RSI) | 45.33 |
| Average Volume (20 Days) | 147,351,166 |
Short Selling Information
| Short Interest | n/a |
| Short Previous Month | n/a |
| Short % of Shares Out | n/a |
| Short % of Float | n/a |
| Short Ratio (days to cover) | n/a |
Income Statement
In the last 12 months, SHE:300142 had revenue of CNY 2.10 billion and earned 188.77 million in profits. Earnings per share was 0.12.
| Revenue | 2.10B |
| Gross Profit | 1.59B |
| Operating Income | 188.83M |
| Pretax Income | 223.28M |
| Net Income | 188.77M |
| EBITDA | 542.75M |
| EBIT | 188.83M |
| Earnings Per Share (EPS) | 0.12 |
Balance Sheet
The company has 1.19 billion in cash and 1.30 billion in debt, with a net cash position of -109.38 million or -0.07 per share.
| Cash & Cash Equivalents | 1.19B |
| Total Debt | 1.30B |
| Net Cash | -109.38M |
| Net Cash Per Share | -0.07 |
| Equity (Book Value) | 7.33B |
| Book Value Per Share | 4.36 |
| Working Capital | 2.10B |
Cash Flow
In the last 12 months, operating cash flow was 548.19 million and capital expenditures -529.76 million, giving a free cash flow of 18.43 million.
| Operating Cash Flow | 548.19M |
| Capital Expenditures | -529.76M |
| Depreciation & Amortization | 353.92M |
| Net Borrowing | 838.79M |
| Free Cash Flow | 18.43M |
| FCF Per Share | 0.01 |
Margins
Gross margin is 75.76%, with operating and profit margins of 9.00% and 9.00%.
| Gross Margin | 75.76% |
| Operating Margin | 9.00% |
| Pretax Margin | 10.64% |
| Profit Margin | 9.00% |
| EBITDA Margin | 25.87% |
| EBIT Margin | 9.00% |
| FCF Margin | 0.88% |
Dividends & Yields
This stock pays an annual dividend of 0.16, which amounts to a dividend yield of 1.18%.
| Dividend Per Share | 0.16 |
| Dividend Yield | 1.18% |
| Dividend Growth (YoY) | 1,450.00% |
| Years of Dividend Growth | n/a |
| Payout Ratio | 545.28% |
| Buyback Yield | -1.20% |
| Shareholder Yield | -0.01% |
| Earnings Yield | 0.91% |
| FCF Yield | 0.09% |
Fair Value
There are several formulas that can be used to estimate the intrinsic value of a stock.
| Lynch Fair Value | |
| Lynch Upside | |
| Graham Number | |
| Graham Upside |
Stock Splits
The last stock split was on October 14, 2015. It was a forward split with a ratio of 3.
| Last Split Date | Oct 14, 2015 |
| Split Type | Forward |
| Split Ratio | 3 |
Scores
SHE:300142 has an Altman Z-Score of 4.68 and a Piotroski F-Score of 5.
| Altman Z-Score | 4.68 |
| Piotroski F-Score | 5 |